The metabolic and endocrine characteristics in spinal and bulbar muscular atrophy

被引：0
作者：
Angela Rosenbohm
Susanne Hirsch
Alexander E. Volk
Torsten Grehl
Julian Grosskreutz
Frank Hanisch
Andreas Herrmann
Katja Kollewe
Wolfram Kress
Thomas Meyer
Susanne Petri
Johannes Prudlo
Carsten Wessig
Hans-Peter Müller
Jens Dreyhaupt
Jochen Weishaupt
Christian Kubisch
Jan Kassubek
Patrick Weydt
Albert C. Ludolph
机构：
[1] University of Ulm,Department of Neurology
[2] University of Hamburg,Institute of Human Genetics, University Medical Center Hamburg
[3] Alfried Krupp Krankenhaus Rüttenscheid,Eppendorf
[4] University of Jena,Department of Neurology
[5] University of Halle,Department of Neurology
[6] Technische Universität Dresden,Department of Neurology
[7] Medical School Hannover,Department of Neurology and German Center for Neurodegenerative Diseases (DZNE), Research Site Dresden
[8] University of Würzburg,Department of Neurology
[9] Charité-Universitätsmedizin Berlin,Institute of Human Genetics
[10] Rostock University Medical Center,Department of Neurology, Outpatient Clinic for ALS and Other Motor Neuron Disorders
[11] Bavaria Clinic,Department of Neurology and German Center for Neurodegenerative Diseases (DZNE)
[12] University of Ulm,Department of Neurology
[13] University of Bonn,Institute of Epidemiology and Medical Biometry
[14] University of Ulm,Department of Neurodegenerative Diseases and Gerontopsychiatry
来源：
Journal of Neurology | 2018年 / 265卷
关键词：
Kennedy’s disease; Spinobulbar muscular atrophy; Motor neuron disease; Diabetes; Biomarker; MRI;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1026 / 1036
页数：10
相关论文
共 157 条
  • [1] La Spada AR(1991)Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy Nature 352 77-79
  • [2] Wilson EM(1999)Tissue-specific somatic mosaicism in spinal and bulbar muscular atrophy is dependent on CAG-repeat length and androgen receptor–gene expression level Am J Hum Genet 65 966-973
  • [3] Lubahn DB(2009)Clinical features of spinal and bulbar muscular atrophy Brain 132 3242-3251
  • [4] Harding AE(2017)Correlation of insulin resistance and motor function in spinal and bulbar muscular atrophy J Neurol 264 839-847
  • [5] Fischbeck KH(2012)Molecular pathophysiology and disease-modifying therapies for spinal and bulbar muscular atrophy Arch Neurol 69 436-440
  • [6] Tanaka F(2013)New routes to therapy for spinal and bulbar muscular atrophy J Mol Neurosci 50 514-523
  • [7] Reeves MF(2012)Developing treatment for spinal and bulbar muscular atrophy Prog Neurobiol 99 257-261
  • [8] Ito Y(2011)Efficacy and safety of dutasteride in patients with spinal and bulbar muscular atrophy: a randomised placebo-controlled trial Lancet Neurol. 10 140-147
  • [9] Rhodes LE(2012)Pathogenesis and therapy of spinal and bulbar muscular atrophy (SBMA) Prog Neurobiol 99 246-256
  • [10] Freeman BK(2015)Clinical trials in spinal and bulbar muscular atrophy-past, present, and future J Mol Neurosci 58 379-387
12345678910